Acquisition of interest in Cellulac plc by Integumen

Synopsis

Acquisition of 9.35% interest in Cellulac plc, an industrial biochemicals investment technology company, by Integumen, a personal health care company. Financial terms were not disclosed.

Principals

target

Cellulac

bidder

Deepverge (integumen Plc)

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy